Bethlem myopathy: genes and variants
Explore variant evidence for Bethlem myopathy across 4 analyzed proteins (COL6A2, COL6A1, COL6A3, LMNA). Linked ClinVar records include 97 pathogenic or likely pathogenic variants, 1,710 variants of uncertain significance and 790 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Bethlem myopathy
COL6A2: Collagen alpha-2(VI) chain
It assembles with other collagen VI chains into extracellular microfibrils that support muscle and connective-tissue integrity. Dominant or recessive pathogenic variants cause collagen VI-related muscular dystrophy and myopathy across a broad severity spectrum.
39 ClinVar pathogenic / likely pathogenic and 635 uncertain variants in COL6A2 have source records linked to Bethlem myopathy. Association strength is not clinical gene validity.
COL6A1: Collagen alpha-1(VI) chain
It contributes to extracellular microfibrils that connect cells with surrounding matrix and are especially important in skeletal muscle and connective tissue. Pathogenic variants can cause collagen VI-related myopathies ranging from Bethlem muscular dystrophy to severe Ullrich congenital muscular dystrophy.
36 ClinVar pathogenic / likely pathogenic and 441 uncertain variants in COL6A1 have source records linked to Bethlem myopathy. Association strength is not clinical gene validity.
COL6A3: Collagen alpha-3(VI) chain
It forms part of collagen VI microfibrils that organize the extracellular matrix around muscle fibers and many other cells. Pathogenic variants can cause Bethlem or Ullrich-spectrum collagen VI myopathy and, in some alleles, isolated dystonia.
21 ClinVar pathogenic / likely pathogenic and 1,424 uncertain variants in COL6A3 have source records linked to Bethlem myopathy. Association strength is not clinical gene validity.
LMNA: Prelamin-A/C
The gene product produces lamins A and C, structural proteins that form the nuclear lamina beneath the inner nuclear membrane. Lamins help maintain nuclear shape and organize chromatin, and LMNA variants are associated with muscular dystrophy, cardiomyopathy, lipodystrophy, and premature-aging syndromes.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in LMNA have source records linked to Bethlem myopathy. Association strength is not clinical gene validity.
Where Bethlem myopathy variants cluster
- COL6A1 Triple-helical region (positions 257–592): 36 of 36 ClinVar pathogenic / likely pathogenic variants, 3.1× more than its size predicts (a length-based count, not a validated hotspot).
- COL6A3 Collagen-like 1 (positions 2038–2097): 13 of 21 ClinVar pathogenic / likely pathogenic variants, 32.8× more than its size predicts (a length-based count, not a validated hotspot).
- COL6A2 Triple-helical region (positions 257–590): 31 of 39 ClinVar pathogenic / likely pathogenic variants, 2.4× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Bethlem myopathy
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| COL6A1 G296R | 296 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A1 G305E | 305 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A1 G272D | 272 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A1 G275E | 275 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A1 G275V | 275 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A1 G278E | 278 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A1 G281E | 281 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A1 G281R | 281 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A1 G290E | 290 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A1 G296E | 296 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A1 G296V | 296 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A1 G302R | 302 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A1 G341D | 341 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A1 G341V | 341 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A1 G341C | 341 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A2 G292V | 292 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A2 G262C | 262 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A2 G262D | 262 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A2 G268S | 268 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A2 G271V | 271 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A2 G271S | 271 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A2 G280R | 280 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A2 G280D | 280 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A2 G283R | 283 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A2 G283E | 283 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A2 G286E | 286 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A2 G292S | 292 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A2 G295R | 295 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A2 G295E | 295 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A2 G301D | 301 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A2 G301S | 301 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A2 D621N | 621 | VWFA 2 | Pathogenic / likely pathogenic (★★) |
| COL6A3 G2053V | 2053 | Collagen-like 1 | Pathogenic / likely pathogenic (★★) |
| COL6A3 G2065R | 2065 | Collagen-like 1 | Pathogenic / likely pathogenic (★★) |
| COL6A3 G2065S | 2065 | Collagen-like 1 | Pathogenic / likely pathogenic (★★) |
| COL6A3 G2074S | 2074 | Collagen-like 1 | Pathogenic / likely pathogenic (★★) |
| COL6A3 G2077D | 2077 | Collagen-like 1 | Pathogenic / likely pathogenic (★★) |
| COL6A3 G2080D | 2080 | Collagen-like 1 | Pathogenic / likely pathogenic (★★) |
| COL6A3 G2080R | 2080 | Collagen-like 1 | Pathogenic / likely pathogenic (★★) |
| COL6A1 G269E | 269 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A1 G287R | 287 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A1 G299R | 299 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A1 G311D | 311 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A1 G380R | 380 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A2 G700D | 700 | VWFA 2 | Pathogenic / likely pathogenic (★★) |
| COL6A2 R876H | 876 | VWFA 3 | Pathogenic / likely pathogenic (★★) |
| COL6A2 G289V | 289 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A3 G1679E | 1679 | VWFA 9 | Pathogenic / likely pathogenic (★★) |
| COL6A3 G2071D | 2071 | Collagen-like 1 | Pathogenic / likely pathogenic (★★) |
| COL6A1 G263V | 263 | Cell attachment site | Pathogenic / likely pathogenic (★★) |
| COL6A2 K318N | 318 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL6A2 C777R | 777 | VWFA 2 | Pathogenic / likely pathogenic (★★) |
| LMNA R541P | 541 | LTD | Pathogenic / likely pathogenic (★★) |
| COL6A1 G305R | 305 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL6A1 G272R | 272 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL6A1 G275R | 275 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL6A1 G275W | 275 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL6A1 G278V | 278 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL6A1 G290W | 290 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL6A1 G290R | 290 | Triple-helical region | Pathogenic / likely pathogenic (★) |
Showing 60 of 97.
Uncertain variants prioritized for review in Bethlem myopathy
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| COL6A1 G287E | 287 | Triple-helical region | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; G287R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98 |
Which prediction tools work for Bethlem myopathy
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 98 out of 100
- PolyPhen-2: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 96 out of 100
- MutPred: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 93 out of 100
- SIFT: 90 out of 100
- phyloP: 87 out of 100
- EVE: 86 out of 100
- SpliceAI: 69 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 50 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Ullrich congenital muscular dystrophy also has ClinVar records linked to COL6A2 variants; they fall partly in the same places as the Bethlem myopathy variants (8 pathogenic / likely pathogenic).
- Charcot-Marie-Tooth disease also has ClinVar records linked to LMNA variants; they fall mostly in different places as the Bethlem myopathy variants (130 pathogenic / likely pathogenic).
- Dilated cardiomyopathy also has ClinVar records linked to LMNA variants; they fall mostly in different places as the Bethlem myopathy variants (21 pathogenic / likely pathogenic).
- Familial partial lipodystrophy, Dunnigan type also has ClinVar records linked to LMNA variants; they fall mostly in different places as the Bethlem myopathy variants (13 pathogenic / likely pathogenic).
- Emery-Dreifuss muscular dystrophy also has ClinVar records linked to LMNA variants; they fall mostly in different places as the Bethlem myopathy variants (12 pathogenic / likely pathogenic).
- Muscular dystrophy due to LMNA mutation also has ClinVar records linked to LMNA variants; they fall mostly in different places as the Bethlem myopathy variants (11 pathogenic / likely pathogenic).
Diseases related to Bethlem myopathy
- Ullrich congenital muscular dystrophy, also linked to COL6A1, COL6A2 and COL6A3
- Collagen 6-related myopathy, also linked to COL6A1, COL6A2 and COL6A3
- Muscular dystrophy, also linked to COL6A2 and LMNA
- Charcot-Marie-Tooth disease, also linked to LMNA
- Dilated cardiomyopathy, also linked to LMNA
- Limb-girdle muscular dystrophy, also linked to LMNA
- Primary dilated cardiomyopathy, also linked to LMNA
- Arrhythmogenic right ventricular dysplasia, also linked to LMNA
- Familial partial lipodystrophy, Dunnigan type, also linked to LMNA
- Emery-Dreifuss muscular dystrophy, also linked to LMNA
- Fetal anomalies with a likely genetic cause, also linked to COL6A3
- Muscular dystrophy due to LMNA mutation, also linked to LMNA
Frequently asked questions
Which genes have records linked to Bethlem myopathy?
This view contains 4 analyzed proteins: COL6A2, COL6A1, COL6A3, LMNA. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 97 pathogenic or likely pathogenic variants, 1,710 variants of uncertain significance and 790 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 2,986 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center